U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804043) titled 'Efficacy of Myopia-control Lenses in a Population of Young Adults : the OPTIMA Study' on Aug. 27.
Brief Summary: The goal of this clinical trial is to learn if myopia-control eyeglass lenses (Essilor(R) Stellest(R) 2.0) can slow down the progression of short-sightedness (myopia) in young adults, compared with standard single-vision lenses. The main questions it aims to answer are:
Does wearing Stellest(R) 2.0 lenses slow the increase in eye length (axial length) after 1 year, compared with standard lenses? Does wearing Stellest(R) 2.0 lenses reduce the change in glasses prescription and the occurrence of eye complications after 2 y...